Table 2. Cox proportional regression model for OS and RFS.
Variables | OS | RFS | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||||||||
HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | |
Sex | ||||||||||||
Male | Reference | 0.247-0.919 | 0.027 | Reference | 0.331-1.296 | 0.224 | Reference | 0.435-1.216 | 0.224 | |||
Female | 0.477 | 0.655 | 0.727 | |||||||||
Age (yr) | ||||||||||||
< 65 | Reference | 1.090-2.545 | 0.018 | Reference | 1.322-3.143 | 0.001 | Reference | 0.909-1.905 | 0.146 | |||
≥ 65 | 1.666 | 2.038 | 1.316 | |||||||||
Smoking | ||||||||||||
Never smoker | Reference | 0.624-1.465 | 0.956 | Reference | 0.657-1.409 | 0.842 | ||||||
Current or former smoker | 0.835 | 0.962 | ||||||||||
Histology | ||||||||||||
SqCC | Reference | 0.400-0.969 | 0.036 | Reference | 0.571-1.456 | 0.698 | Reference | 0.505-1.087 | 0.126 | |||
Non-SqCC | 0.623 | 0.911 | 0.741 | |||||||||
ECOG PS | ||||||||||||
0 | Reference | 0.932-2.146 | 0.104 | Reference | 1.041-2.187 | 0.030 | Reference | 0.985-2.113 | 0.060 | |||
1 | 1.414 | 1.509 | 1.443 | |||||||||
Surgery | ||||||||||||
Lobectomy and others | Reference | 0.660-1.993 | 0.626 | Reference | 0.849-2.182 | 0.201 | ||||||
Pneumonectomy | 1.147 | 1.361 | ||||||||||
TNM stage | ||||||||||||
pI | Reference | Reference | Reference | Reference | ||||||||
pII | 1.439 | 0.922-2.246 | 0.109 | 1.400 | 0.887-2.210 | 0.149 | 1.636 | 1.096-2.442 | 0.016 | 1.628 | 1.086-2.438 | 0.018 |
pIII | 2.260 | 1.318-3.876 | 0.003 | 2.222 | 1.248-3.954 | 0.007 | 2.950 | 1.812-4.804 | < 0.001 | 2.350 | 1.394-3.962 | 0.001 |
PLT-PLR | ||||||||||||
0 | Reference | Reference | Reference | Reference | ||||||||
1 | 1.360 | 0.882-2.099 | 0.148 | 1.356 | 0.886-2.075 | 0.161 | 1.204 | 0.818-1.774 | 0.310 | 1.248 | 0.853-1.828 | 0.254 |
2 | 3.787 | 1.986-7.220 | < 0.001 | 3.473 | 1.765-6.835 | < 0.001 | 3.087 | 1.712-5.565 | < 0.001 | 2.286 | 1.243-4.206 | 0.008 |
Abbreviation: OS, overall survival; RFS, relapse-free survival; HR, hazard ratio; 95% CI, 95% confidence interval; SqCC, squamous cell carcinoma; Non-SqCC, non-squamous cell carcinoma; ECOG PS, Eastern Cooperative Oncology Group Performance Status; PLT, platelet; PLR, platelet-to-lymphocyte ratio